Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Obesity: Adipogenesis and Insulin Resistance.

J K Sethi1

  • 1University of Cambridge, Department of Clinical Biochemistry, Addenbrooke's Hospital, Box 232, Hills Road, Cambridge, CB2 2QR. jks30@cam.ac.uk

Idrugs : the Investigational Drugs Journal
|August 2, 2005
PubMed
Summary

This meeting highlighted molecular mechanisms in adipogenesis and insulin resistance for drug discovery. New compounds targeting obesity and diabetes, including PPARgamma antagonists and insulin sensitizers, were discussed.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

LEM-PCR: a method for determining relative transcript isoform proportions using real-time PCR without a standard curve.

Genome·2010
Same author

Secreted frizzled-related protein 1 regulates adipose tissue expansion and is dysregulated in severe obesity.

International journal of obesity (2005)·2010
Same author

Tumour necrosis factor-alpha inhibits adipogenesis via a beta-catenin/TCF4(TCF7L2)-dependent pathway.

Cell death and differentiation·2007
Same author

WNT10B mutations in human obesity.

Diabetologia·2006
Same author

Characterisation of receptor-specific TNFalpha functions in adipocyte cell lines lacking type 1 and 2 TNF receptors.

FEBS letters·2000
Same author

Transmembrane tumor necrosis factor (TNF)-alpha inhibits adipocyte differentiation by selectively activating TNF receptor 1.

The Journal of biological chemistry·1999

Area of Science:

  • Biochemistry
  • Pharmacology
  • Metabolic Diseases

Background:

  • Adipogenesis and insulin resistance are key processes in metabolic diseases.
  • Understanding molecular mechanisms is crucial for developing effective treatments.
  • Obesity and diabetes represent significant global health challenges.

Purpose of the Study:

  • To review recent advancements in adipogenesis and insulin resistance research.
  • To identify potential drug discovery targets for obesity and diabetes.
  • To discuss novel compounds with therapeutic potential.

Main Methods:

  • Focus on molecular mechanisms relevant to drug discovery.
  • Presentation of new chemical entities and their properties.
  • Discussion of compounds in preclinical and clinical development.

Main Results:

  • Identified LIFR antagonist (hLIF05) as a potential therapeutic agent.
  • Characterized LG-100641, a selective PPARgamma antagonist with insulin-sensitizing effects.
  • Reviewed small molecule insulin sensitizers like CLX-0901, TLK-17411, and S-15261.

Conclusions:

  • Novel molecular targets and compounds show promise for treating obesity and diabetes.
  • Further research into these agents could lead to new therapeutic strategies.
  • The development of insulin sensitizers remains an active area of pharmaceutical research.

Related Experiment Videos